XWELL, Inc. Common Stock

Day range

$0.71 – $0.77

Open

$0.71

Prev close

$0.68

Volume

53.48K

Market cap

$6.81M

Shares out

10.62M

P/E

—

P/S

0.24

P/B

-3.66

P/FCF

—

ROE

1798.7%

ROA

-162.5%

Debt/Equity

0.00

Div yield

0.28%

As of Oct 23, 2026

• Listing deficiency noticeOct 20, 2026

  Under Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided a compliance period of 180 calendar days, or until April 5, 2027, to regain compliance with the Minimum Bid Price Requirement.

• Acquisition agreementOct 8, 2026

  As previously announced, on July 6, 2026, XWELL entered into a Securities Purchase Agreement ... in accordance with the terms and subject to the conditions of which, among other things, XWELL will sell, assign, transfer and convey to the Buyer all of XWELL's equity interests in XpresSpa and XpresTest (the 'Sale').

• Director departureAug 5, 2026

  On August 3, 2026, Ezra T. Ernst, the President, Chief Executive Officer and director of XWELL, Inc. (the "Company"), notified the Company of his resignation as a director of the Company's Board of Directors (the "Board") and all committees of the Board thereto, effective as of the same date. Mr. Ernst's resignation from the Board was not in connection with any disagreement with the Company on any matter relating to the Company's operations, policies or practices.

• Divestiture agreementJul 9, 2026

  On July 6, 2026, XWELL, Inc. entered into a Securities Purchase Agreement by and among XWELL, XpresSpa Holdings, LLC, XpresTest, Inc., and Express Wellness Group, LLC, in accordance with which XWELL will sell, assign, transfer and convey to the Buyer all of XWELL's equity interests in the Target Companies (the 'Sale').

• Charter amendmentMar 4, 2026

  On March 4, 2026, in connection with the Repurchase, the Company filed a Certificate of Elimination (the "Certificate of Elimination") with respect to the Series G Preferred Stock with the Delaware Secretary of State... The Certificate of Elimination (i) eliminates the previous designation of 4,000 shares of Series G Convertible Preferred Stock... (iii) eliminates all reference to the Series G Preferred Stock from the Company's Amended and Restated Certificate of Incorporation, as amended.

Days to cover

5.3

Short interest

143.23K

Avg volume

26.87K

As of Sep 30, 2026 · reported to FINRA twice monthly.

• XWELL Strengthens Florida Presence with Bloomingdale Wellness Center Grand Opening
  positiveGlobeNewswire Inc.· Sep 12, 2025
• XWELL Announces Senior Leadership Appointments and Changes
  positiveGlobeNewswire Inc.· Jan 7, 2025
• Open Letter to XWELL Shareholders from CEO Ezra Ernst
  positiveGlobeNewswire Inc.· Dec 5, 2024
• XWELL Continues to Innovate in Airport Wellness Space with New Massage Solutions: Introducing Ceragem V6 in select XpresSpa® Locations in US
  GlobeNewswire Inc.· May 23, 2024
• XWELL, Inc. Reports First Quarter 2024 Results
  GlobeNewswire Inc.· May 15, 2024